MEDICAMENTOUS FORM

摘要

The medicamentous form of pyroxycam-beta cyclodextrine is used as nonsteroid antiphlogistic form for the treatment of rheumatic arthritis, chronic arthrities, osteoarthritis, sciatica, discopathia, Bekhterev's disease and others. It is stable and includes, as auxiliary substances, lactose monohydrate 0.15-0,20 g, wheat starch from 10.0 to 25.0 mg, a-starch glyconate (carboxymethyl starch) from 20.0 to 55.0 mg, colloid silicon dioxide from 1.0 to 4.0 mg, magnesium stearate from 1.0 to 5.0 mg and, optionally, povidon from 5.0 to 20 mg. 3 claims